| [1] |
Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu.
Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415.
|
| [2] |
Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong.
Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023)
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431.
|
| [3] |
An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui.
Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438.
|
| [4] |
Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long.
Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476.
|
| [5] |
Senior Department of Tuberculosis, the 8th Medical Center of Chinese PLA General Hospital , Editorial Board of Chinese Journal of Antituberculosis , Basic and Clinical Speciality Committees of Tuberculosis Control Branch of China International Exchange , Promotive Association for Medical and Health Care .
Expert consensus on multidisciplinary diagnosis and treatment of tuberculous peritonitis
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 243-257.
|
| [6] |
Duan Hongfei, Tao Yong.
Interpretation of social organization standard of Diagnosis Specification of Intraocular Tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 258-261.
|
| [7] |
Jia Hui, Jing Hui, Ling Xiaojie, Wang Yan, Li Xuezheng.
The diagnostic value of GeneXpert MTB/RIF Ultra in detecting sputum samples for newly diagnosed pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 298-304.
|
| [8] |
Shi Yuru, Gu Dejian, Wu Jing, Liu Ting, Qin Linghan, Yue Li, Qi Yingjie.
Diagnostic value of probe capture-based targeted next-generation sequencing and metagenomic next-generation sequencing for detecting Mycobacterium tuberculosis in bronchoalveolar lavage fluid
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 305-311.
|
| [9] |
Yang Haixia, Zhang Xiaoyan, Huang Yi, Li Qiu.
Effective and safety of concurrent intensity-modulated radiotherapy and anti-tuberculosis chemotherapy in patients with active pulmonary tuberculosis comorbid with thoracic tumor
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 312-321.
|
| [10] |
Yang Ziyi, Chen Suting.
Research progress on bedaquiline resistance and drug resistance diagnosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 374-379.
|
| [11] |
Qiu Yong, Quan Zhuo, Qu Rong, Tian Fajun, Li Meng, Wang Gengsheng, Wang Ya, Guo Mingcheng, Gao Qian.
Evaluation of different tuberculosis diagnostic tools for detecting patients in a primary-level clinic in rural China: a real-world retrospective study
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 181-188.
|
| [12] |
Xue Yu, Yang Xinting, Wang Guirong, Liu Fangchao, Lei Xuan, Zhang Jing, Li Liang.
Analysis of risk factors for death in emergency pulmonary tuberculosis patients and risk model construction
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 189-194.
|
| [13] |
Wang Dafu, Ma Xiaoxue, Wang Yun, Li Fudong, Rao Wen, Gong Tingting, Li Shijun, Li Jinlan.
Analysis of risk factors for patient delay and adverse treatment outcomes among patients with pulmonary tuberculosis and diabetes mellitus in Guizhou Province, 2016—2023
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 201-209.
|
| [14] |
Li Fudong, Ma Xiaoxue, Zhou Jian, Wang Dafu, Zhang Yueying, Gong Tingting, Rao Wen, Hong Feng, Li Shijun, Li Jinlan.
Characteristics and treatment outcome analysis of MTB/HIV dual infection patients in Guizhou Province from 2018 to 2023
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 36-43.
|
| [15] |
Zhao Yue, Wang Haoran, Cheng Meijin, Wang Wei, Liang Ruixia, Huang Hairong.
The evaluation of the smear-positive and Xpert-negative outcome as an early indicator of nontuberculous mycobacteria existence in clinical specimen
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 61-65.
|
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
